Disclosure Panels Details Page
Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenström Macroglobulinemia Panel - Disclosures as of 03/04/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Kehinde Adekola MD, MSCI | Blood and Marrow Transplant Clinical Trials Network - BMT CTN NHLBI Data and Safety Monitoring Board (DSMB) |
None | None | None | - |
| Larry Anderson, Jr. MD, PhD | AbbVie, Inc. Bristol Myers Squibb Cellectar GSK Janssen Pharmaceutica Products, LP Prothena |
AbbVie, Inc. BeiGene Bristol Myers Squibb Celgene Corporation Cellectar GSK Janssen Pharmaceutica Products, LP Prothena sanofi-aventis U.S. |
None | None | - |
| Muhamed Baljevic MD | None | Bristol Myers Squibb Janssen Biotech Sanofi-Genzyme |
CancerNetwork Cardinal Health Curio Science NCCN OncLive Targeted Oncology |
None | - |
| Rachid Baz MD | AbbVie, Inc. arvinas Bristol Myers Squibb Daiichi- Sankyo Co. Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Marker Therapeutics Pfizer Inc. pionyr immunotherapeutics quantum leap healthcare collaborative Regeneron Pharmactcls SeaGen Zymeworks |
Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP |
cancer network curio science HIKMA cancer network SOHO MENA |
None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Nicole Blankenhorn | None | None | None | None | - |
| Natalie Callander MD | None | None | None | None | - |
| Erica Campagnaro MD | None | None | None | None | - |
| Jorge Castillo MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP BeiGene Cellectar Eli Lilly and Company Pharmacyclics |
AbbVie, Inc. BeiGene Cellectar Janssen Pharmaceutica Products, LP Kite Pharma LOXO Pharmacyclics |
None | None | - |
| Caitlin Costello MD | Multiple Myeloma Research Foundation | Celgene Corporation Janssen Pharmaceutica Products, LP Pfizer Inc. Regeneron Pharmactcls Takeda Pharmaceuticals North America, Inc. |
None | None | - |
| Christopher D'Angelo MD | BeiGene Bristol Myers Squibb Curis Inc Fate Therapeutics |
None | AbbVie, Inc. Bristol Myers Squibb SeaGen |
None | - |
| Benjamin Derman MD | Amgen Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Novartis Pharmaceuticals Corporation |
Bristol Myers Squibb | COTA, INC. Janssen Pharmaceutica Products, LP |
None | - |
| Srinivas Devarakonda MD | None | None | None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Mary Dwyer MS | None | None | None | None | - |
| Noura Elsedawy MD | GSK | None | None | Vyriad | - |
| Meghan Fay BSN, RN, OCN | None | None | None | None | - |
| Amandeep Godara MD | None | None | None | None | - |
| Kelly Godby MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Erin Hesler | None | None | None | None | - |
| Jens Hillengass MD, PhD | Amgen Inc. Bristol Myers Squibb Fate therapeutics Gilead Sciences, Inc. GSK Harpoon IGM Biosciences, Inc. Janssen Pharmaceutica Products, LP Pfizer Inc. Poseida Prothena sanofi-aventis U.S. |
Aptitude Health GSK Intellisphere Janssen Pharmaceutica Products, LP Oncopeptides Prothena sanofi-aventis U.S. Sebia Skyline |
None | None | - |
| Leona Holmberg MD, PhD | Bristol Myers Squibb ITeos Merck & Co., Inc. sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
Bioline RX | None | Up-To-Date | - |
| Myo Htut MD | Celgene Corporation Janssen Pharmaceutica Products, LP |
None | None | None | - |
| Carol Ann Huff MD | Glenmark / Ichnos Prothena |
sanofi-aventis U.S. | None | None | - |
| Malin Hultcrantz MD, PhD | AbbVie, Inc. BeiGene Daiichi- Sankyo Co. GSK Springworks |
Bristol Myers Squibb GSK Johnson & Johnson |
None | None | - |
| Yubin Kang MD | Karyopharm Therapeutics Takeda Pharmaceuticals North America, Inc. |
None | None | None | - |
| Emily Kovach | None | None | None | None | - |
| Rashmi Kumar PhD | None | None | None | None | - |
| Shaji Kumar MD | AbbVie, Inc. Allogene Arcellx Bristol Myers Squibb Carsgen GSK Janssen Pharmaceutica Products, LP Roche Laboratories, Inc. Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. Bristol Myers Squibb GSK Pfizer Inc. Regeneron Pharmaceuticals, Inc. Roche Laboratories, Inc. sanofi-aventis U.S. Takeda Pharmaceuticals North America, Inc. |
None | None | - |
| Sarah Larson MD | AbbVie, Inc. Allogene Bristol Myers Squibb Celgene Corporation Janssen Pharmaceutica Products, LP Juno Therapeutics, Inc. Pfizer Inc. sanofi-aventis U.S. |
1200 Pharma TORL Biotherapeutics |
Oncovalent | None | - |
| Hans Lee MD | Allogene Therapeutics Amgen Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP National Cancer Institute Regeneron Pharmaceuticals, Inc. Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Regeneron Pharmactcls sanofi-aventis U.S. |
None | None | - |
| Michaela Liedtke MD | AbbVie, Inc. Allogene Biomea Bristol Myers Squibb Caelum Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP SeaGen |
AbbVie, Inc. Bristol Myers Squibb Nexcella |
None | None | - |
| Thomas Martin MD | Amgen Inc. Bristol Myers Squibb Janssen Pharmaceutica Products, LP sanofi-aventis U.S. |
Eli Lilly and Company GSK Pfizer Inc. |
None | None | - |
| John Murphy | None | None | None | None | - |
| Jim Omel MD | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Timothy Robinson MD, PhD | I have a lab and conduct research that has been previously funded by the NIH/NCI and upcoming funding from the American Cancer Society Wife/spouse is co-leader of cancer prevention and control for Yale Cancer Center. She conducts NIH and ACS funded research as a principle investigator. No perceived conflicts of interest. |
Kite Pharma | None | I have patents related to splicing-based therapeutics and theragnostics. None are currently licensed. Unrelated to multiple myeloma or NCCN guidelines. | - |
| Aaron Rosenberg MD | Biomea GSK Kangpu Biopharmaceuticals Sorento Takeda Pharmaceuticals North America, Inc. |
Kangpu Biopharmaceuticals | None | None | - |
| Mark Schroeder MD | Fate Therapeutics, Inc. Ichnos Sciences SA Incyte Corporation Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Kura Oncology (through IQVIA CRO) Marker Therapeutics (through Advarra CRO) Sorrento (through Advarra CRO) Takeda Pharmaceuticals North America, Inc. |
None | None | None | - |
| Daniel Sherbenou MD, PhD | Karyopharm Therapeutics Pfizer Inc. sanofi-aventis U.S. |
None | None | None | - |
| Attaya Suvannasankha MD | Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Regeneron Pharmactcls SUTRO Biopharma, Inc. |
Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP |
None | None | - |
| Jason Valent MD | AbbVie, Inc. Alexion Pharmaceuticals, Inc. Allogene therapeutics Amgen Inc. Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Pfizer Inc. Pharmacyclics Prothena Biosciences |
None | None | none | - |
| Asya Nina Varshavsky-Yanovsky MD, PhD | Bristol Myers Squibb Pfizer Inc. |
Bristol Myers Squibb GSK Janssen Pharmaceutica Products, LP Pfizer Inc. |
None | None | - |
| Erin Vidic | None | None | None | None | - |
| Dan Vogl MD | AbbVie, Inc. Active Biotech AB Caelum Biosciences CRISPR Therapeutics Genentech, Inc. GSK Janssen Pharmaceutica Products, LP Phosplatin Therapeutics Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. Genentech, Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | - |